A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India
about
The case for reactive mass oral cholera vaccinationsCritical analysis of compositions and protective efficacies of oral killed cholera vaccinesVaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio choleraeImproving immunization approaches to cholera.Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A VirusOral vaccines against cholera.Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, IndiaMaximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with choleraChloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery.A large study on immunological response to a whole-cell killed oral cholera vaccine reveals that there are significant geographical differences in response and that O blood group individuals do not elicit a higher responseCholera in India: an analysis of reports, 1997-2006Testing vaccines in pediatric research subjects.Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India.Killed oral cholera vaccines: history, development and implementation challengesIs Vibrio fluvialis emerging as a pathogen with epidemic potential in coastal region of eastern India following cyclone Aila?Vibrio cholerae: lessons for mucosal vaccine design.Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.Preparation and immunogenicity of conjugate based on hydrazine-treated lipopolysaccharide antigen of Vibrio cholerae O139.Review of oral cholera vaccines: efficacy in young children.A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in EthiopiaImmune responses to cholera in children.Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian AdultsOral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh.Safety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea.New-generation vaccines against cholera.Cholera: pathophysiology and emerging therapeutic targets.Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era.Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings.Infection: mass vaccination is feasible in response to cholera epidemics.The role of immunity and seasonality in cholera epidemics.Dynamics analysis of a multi-strain cholera model with an imperfect vaccine.Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.Public health. The cholera crisis in Africa.Causes of impaired oral vaccine efficacy in developing countries.Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.Cholera
P2860
Q21144515-24D814AC-1527-4787-BD82-D4BABA829F17Q26823170-6E21006F-DA4E-41C2-823C-A4A219781235Q27004488-D9FA11A5-E167-49B4-9A4A-16FA55BE7693Q30151668-8AF2F333-4094-458D-A8E5-8159755A11EEQ30401849-9DAAEC17-56FC-4C65-BD8B-FC5CEF2D48D0Q30401927-6C1EB205-B25B-4074-AFDC-9DA2C08DF801Q33572955-532A799C-1617-4302-8C84-C531FD6A6882Q33578033-2286A5F3-E795-4CCA-BF8E-8F07A8FB22F1Q33588522-79FEF64A-41C7-4977-94CB-8CCAD8BC5570Q33596284-0A6C70DE-C5DE-4B26-BFC8-16AB7BFDC166Q33606727-ED4E7CD9-8AB5-416B-B6C2-4F804864D050Q33689166-A6998E2B-9383-4ED8-A864-3FF31BAD4187Q33701535-1E1EAEC3-3E3C-4E1D-A264-2C585966384EQ33830466-0BB406C9-9970-4725-B83D-E6180A4E3C86Q34087755-BA96B550-8BA6-49BE-B5EA-25C8990FD19CQ34247216-C0895404-3124-4C12-A8C9-E8A871E60718Q34562952-1670F3C0-45C6-4DA7-B413-2CA7638CFB91Q35066200-B4FD3C76-CDB3-4B52-B804-1F28CA112D65Q35170821-A64DE71B-D365-4364-91CB-7BC693AEC629Q35214487-DF551FBE-D64E-45DA-B8C3-14FFB8BB1804Q35547754-0C56D124-DB60-4669-9FB3-C0D2659819D6Q36026263-D5C04C31-4906-4505-94A6-672B06D9BB1DQ36044030-E740F61A-E7C7-40CD-ADBA-7FC290FBEDACQ36053849-733CB2E0-AA4E-41B5-82D1-4EC709E4AD29Q36640081-C2540FE8-B4BA-4FEC-AC6D-6DF79765E662Q37640110-9854D64D-566F-4954-A1BE-E715CFEDE59EQ37686863-44120BC9-1824-4917-8935-CEB22A0499F5Q37710341-82A96D1A-BFC1-4778-A5B2-031C20F7F2F1Q37953796-DFA6BFB8-D848-4CE1-948E-E6AAA52E9EDDQ38104753-207CDA12-7F45-40E1-AC87-BA09EB21A401Q38376033-ABD6A4C8-DED2-40EB-8CB7-60F2A39DBDC5Q41039072-95A90D41-4DC2-477B-B867-EDEBA2FB8099Q42240170-D8FCFEAC-13B0-4B6C-B4A9-072FD7BD96BDQ43328254-9AFFAB42-89E4-4C9E-AECE-41F448E49578Q45277848-F0E0CD0E-DB2E-4A0C-9B48-BAABAAF53150Q46246286-14F513FA-6489-46F7-A2D3-1CE8343A8701Q46887189-927D727C-6E6A-4FEC-83F2-E0D38439AD53Q47794110-D1A210FE-3062-4CBC-A5DB-2DA4FC314CA3Q48344793-BDC57777-3359-42E8-8BF0-92A5E04F80ECQ55890255-2822357F-C474-40D3-BCFD-E22894B6C6F7
P2860
A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A randomized, placebo-controll ...... endemic area in Kolkata, India
@ast
A randomized, placebo-controll ...... endemic area in Kolkata, India
@en
A randomized, placebo-controll ...... endemic area in Kolkata, India
@en-gb
A randomized, placebo-controll ...... endemic area in Kolkata, India
@nl
type
label
A randomized, placebo-controll ...... endemic area in Kolkata, India
@ast
A randomized, placebo-controll ...... endemic area in Kolkata, India
@en
A randomized, placebo-controll ...... endemic area in Kolkata, India
@en-gb
A randomized, placebo-controll ...... endemic area in Kolkata, India
@nl
prefLabel
A randomized, placebo-controll ...... endemic area in Kolkata, India
@ast
A randomized, placebo-controll ...... endemic area in Kolkata, India
@en
A randomized, placebo-controll ...... endemic area in Kolkata, India
@en-gb
A randomized, placebo-controll ...... endemic area in Kolkata, India
@nl
P2093
P2860
P921
P3181
P1433
P1476
A randomized, placebo-controll ...... endemic area in Kolkata, India
@en
P2093
Anna Lena Lopez
Byomkesh Manna
Dilip Mahalanabis
Dipika Sur
Jacqueline Deen
John Clemens
Rodney Carbis
Seong Hye Shin
Seung Hyun Han
P2860
P3181
P356
10.1371/JOURNAL.PONE.0002323
P407
P577
2008-01-01T00:00:00Z